NASDAQ:GELS - Nasdaq - AU0000218109 - Common Stock - Currency: USD
2.66
-0.22 (-7.64%)
The current stock price of GELS is 2.66 USD. In the past month the price increased by 150.94%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 63.8 | 786.28B | ||
JNJ | JOHNSON & JOHNSON | 15.46 | 374.44B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 17.67 | 272.11B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.87 | 217.52B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 16.51 | 212.41B | ||
MRK | MERCK & CO. INC. | 10.31 | 198.14B | ||
SNY | SANOFI-ADR | 11.83 | 129.80B | ||
PFE | PFIZER INC | 7.2 | 126.98B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 42.57 | 98.75B | ||
GSK | GSK PLC-SPON ADR | 8.51 | 75.03B | ||
ZTS | ZOETIS INC | 25.49 | 67.31B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 32.3 | 47.78B |
Gelteq Ltd. is a biotechnology company. The company is headquartered in Melbourne, Victoria and currently employs 7 full-time employees. The company went IPO on 2024-10-29. The firm is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The firm offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The firm also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
GELTEQ LTD
Level 4, 100 Albert Road
Melbourne VICTORIA AU
Employees: 7
Company Website: https://www.gelteq.com
Investor Relations: https://ir.gelteq.com/
Phone: 61390873990
The current stock price of GELS is 2.66 USD. The price decreased by -7.64% in the last trading session.
The exchange symbol of GELTEQ LTD is GELS and it is listed on the Nasdaq exchange.
GELS stock is listed on the Nasdaq exchange.
GELTEQ LTD (GELS) has a market capitalization of 25.11M USD. This makes GELS a Nano Cap stock.
GELTEQ LTD (GELS) currently has 7 employees.
GELTEQ LTD (GELS) has a resistance level at 2.89. Check the full technical report for a detailed analysis of GELS support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
GELS does not pay a dividend.
GELTEQ LTD (GELS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.24).
The outstanding short interest for GELTEQ LTD (GELS) is 0.19% of its float. Check the ownership tab for more information on the GELS short interest.
ChartMill assigns a technical rating of 4 / 10 to GELS.
ChartMill assigns a fundamental rating of 1 / 10 to GELS. Both the profitability and financial health of GELS have multiple concerns.
Over the last trailing twelve months GELS reported a non-GAAP Earnings per Share(EPS) of -0.24. The EPS decreased by -1.13% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -17.08% | ||
ROE | -23.47% | ||
Debt/Equity | 0.12 |